Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Strategic Framework for Community Engagement in Oceans and Human Health.
Carson MA, Doberneck DM, Hart Z, Kelsey H, Pierce JY, Porter DE, Richlen ML, Schandera L, Triezenberg HA. Carson MA, et al. Among authors: hart z. Community Sci. 2022 Jun;1(1):e2022CSJ000001. doi: 10.1029/2022csj000001. Epub 2022 Apr 14. Community Sci. 2022. PMID: 36186152 Free PMC article.
Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
Zhou Q, van den Berg NS, Kang W, Pei J, Nishio N, van Keulen S, Engelen MA, Lee YJ, Hom M, Vega Leonel JCM, Hart Z, Vogel H, Cayrol R, Martin BA, Roesner M, Shields G, Lui N, Gephart MH, Raymundo RC, Yi G, Granucci M, Grant GA, Li G, Rosenthal EL. Zhou Q, et al. Among authors: hart z. J Nucl Med. 2022 Nov;63(11):1693-1700. doi: 10.2967/jnumed.121.263674. Epub 2022 Mar 24. J Nucl Med. 2022. PMID: 35332092 Free PMC article.
Resistance to Molecularly Targeted Therapies in Melanoma.
Patel M, Eckburg A, Gantiwala S, Hart Z, Dein J, Lam K, Puri N. Patel M, et al. Among authors: hart z. Cancers (Basel). 2021 Mar 5;13(5):1115. doi: 10.3390/cancers13051115. Cancers (Basel). 2021. PMID: 33807778 Free PMC article. Review.
Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
Lu G, van den Berg NS, Martin BA, Nishio N, Hart ZP, van Keulen S, Fakurnejad S, Chirita SU, Raymundo RC, Yi G, Zhou Q, Fisher GA, Rosenthal EL, Poultsides GA. Lu G, et al. Among authors: hart zp. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):753-764. doi: 10.1016/S2468-1253(20)30088-1. Epub 2020 May 14. Lancet Gastroenterol Hepatol. 2020. PMID: 32416764 Free PMC article. Clinical Trial.
35 results